Antinociceptive effect of triazine derivatives in acetic acid-induced writhing test in mice

Compound Dose (mg/kg) Number of writhings Percent inhibition
Control 69.9 ± 3.5
5c 50 27.8 ± 3.1*** 60%
100 19.7 ± 7.6*** 71%
200 15.5 ± 6.6*** 77%
5d 50 18.5 ± 6.2*** 73%
100 6.4 ± 5.5*** 90%
200 6.0 ± 3.9*** 91%
10a 50 7.7 ± 3.5*** 88%
100 7.5 ± 4.4*** 89%
200 2.8 ± 1.0*** 95%
10b 50 16.8 ± 3.9*** 75%
100 13.4 ± 3.9*** 80%
200 1.0 ± 0.8*** 98%
10e 50 31.7 ± 3.0*** 54%
100 7.5 ± 0.4*** 89%
200 4.7 ± 2.2*** 93%
Indomethacin 10 3.3 ± 1.3*** 95%

Data shows mean ± SEM of six mice in each group.

5c: 4-(4-(4-formyl-3-methoxyphenoxy)−6–chloro-1,3,5-triazin-2-ylamino)benzonitrile, 5d: 4-(4-(p-tolylamino)−6–chloro-1,3,5-triazin-2-yloxy)−2-methoxybenzaldehyde, 10a: 4–chloro-N-methyl-6-(4-phenyl-1H-pyrazol-1-yl)−1,3,5-triazin-2-amine, 10b: 4–chloro-N-ethyl-6-(4-phenyl-1H-pyrazol-1-yl)−1,3,5-triazin-2-amine, 10e: 2,4-dichloro-6-(4-phenyl-1H-pyrazol-1-yl)−1,3,5-triazine, SEM: standard error of the mean.

***P < 0.001 compared to control group.

Korean J Pain 2022;35:440~446 https://doi.org/10.3344/kjp.2022.35.4.440
© Korean J Pain